Human isoprenoid synthase enzymes as therapeutic targets

J Park, AN Matralis, AM Berghuis… - Frontiers in …, 2014 - frontiersin.org
In the human body, the complex biochemical network known as the mevalonate pathway is
responsible for the biosynthesis of all isoprenoids, which consists of a vast array of …

Most appropriate animal models to study the efficacy of statins: a systematic review

V Pecoraro, L Moja, L Dall'Olmo… - European Journal of …, 2014 - Wiley Online Library
Background In animal models and clinical trials, statins are reported as effective in reducing
cholesterol levels and lowering the risk of cardiovascular diseases. We have aggregated the …

Multi-target drug design approaches for multifactorial diseases: From neurodegenerative to cardiovascular applications

MG Katselou, AN Matralis… - Current medicinal …, 2014 - ingentaconnect.com
In multi-target drug design (MTD) medicinal chemistry aims to integrate multiple
pharmacophores into a single drug molecule in order to make it active on several molecular …

Potential role of nonstatin cholesterol lowering agents

L Trapani, M Segatto, P Ascenzi, V Pallottini - IUBMB life, 2011 - Wiley Online Library
Abstract Although statins, 3β‐hydroxy‐3β‐methylglutaryl coenzyme A reductase (HMGR)
inhibitors, have revolutionized the management of cardiovascular diseases by lowering …

Antihyperlipidemic morpholine derivatives with antioxidant activity: An investigation of the aromatic substitution

EM Ladopoulou, AN Matralis, A Nikitakis… - Bioorganic & medicinal …, 2015 - Elsevier
Drugs affecting more than one target could result in a more efficient treatment of
multifactorial diseases as well as fewer safety concerns, compared to a one-drug one-target …

Lipid-lowering (hetero) aromatic tetrahydro-1, 4-oxazine derivatives with antioxidant and squalene synthase inhibitory activity

AP Kourounakis, C Charitos, EA Rekka… - Journal of medicinal …, 2008 - ACS Publications
A number of newly synthesized 2-[4-(hetero) aromatic] phenyl-2-hydroxy-tetrahydro-1, 4-
oxazine derivatives were found to inhibit lipid peroxidation (IC50 of the most potent was 20 …

Squalene synthase inhibitors: An update on the search for new antihyperlipidemic and antiatherosclerotic agents

AP Kourounakis, MG Katselou… - Current medicinal …, 2011 - ingentaconnect.com
Atherosclerosis and related heart disease is strongly associated with elevated blood levels
of total (and LDL) cholesterol. Due to the widespread incidence as well as severity of this …

[图书][B] Chemistry and molecular aspects of drug design and action

EA Rekka, PN Kourounakis - 2008 - taylorfrancis.com
An ever-increasing demand for better drugs, elevated safety standards, and economic
considerations have all led to a dramatic paradigm shift in the way that drugs are being …

Effect of a new squalene synthase inhibitor on an ApoE−/− mouse model of atherosclerosis

AN Matralis, L Kaklamanis, D Perrea… - Bioorganic & Medicinal …, 2023 - Elsevier
Ηypercholesterolemia/hyperlipidemia in conjunction with oxidative stress and inflammatory
processes contribute synergistically to the pathogenesis of atherosclerosis. We hereby …

[HTML][HTML] Antioxidant and anti-inflammatory effects of Marrubium alysson extracts in high cholesterol-fed rabbits

SS Essawy, DM Abo-Elmatty, NM Ghazy… - Saudi Pharmaceutical …, 2014 - Elsevier
The antioxidant and anti-inflammatory effects of hexane (HEXA), chloroform (CHLORO),
ethyl acetate (EA) and total alcoholic (T. ALCOH) extracts of Marrubium alysson in …